Skip to main content

Maintain supply of knee implants, govt tells firms

Maintain supply of knee implants, govt tells firms
The government on tuesday made it manadatory for knee implant manufactures and importers to maintain production and supply of knee implants by invoking an emergency clause under the derug price control law.
The department of pharmeuticals (DoP) under the ministry of chemicals and fertilizers invoked powers under the Drugs (Prices Control) Order, 2013, to mandate firms to continue the saler iof knee implants without interruption, following the recent price capping on knee impants. DoP, in its order posted on its websitre on Tuesday, directed firms to submit a weekly report on "distributuion and "production"of knee implant systems.

The National Pharmaceutical Pricing Authority (NPPA) had in August reduced the average price for knee impant by as mych as 69%.According to notification issued by the price regulator, the most widely used complete knee implant (Cobalt Chromium) now costs Rs 54,720 plus GST, gainst Rs 1.58 lakh earlier.
NPPA also capped the price of a second surgery to Rs 1.3 lakh against Rs 2.76 lajkh earlier. Prices of Specil metals such as Titanium and Oxidised Ziorconium were also capped at Rs 76,600 (prices of these were not capped earlier: they used to cost Rs 2.49 lakh). The government has asked manufacturers to maintain production important supply of Orthopedic knee implant system that existed before august then the price caps weere announced under section 3 (i) of DPCO, 2013 The government can regulate distribution in direct any manufacturer tidays production and sale products to institution hospitals or any agency may be in case of emergency or in circumstances urgencfy or in case of non-commercial use of public interest

With the view to acheive adequate availability and regulate distribvution of drug in case of emergency or in circumstances of urgency or in caswe of non-commercuia use in public interestdirect any manufacturer of any active farmer suitable ingredient or drug or formulation to increse production into direct formulaters to serve the formulation to institutions,hospitals or any agency,"Dop said in its order .

Additionally,the companies are also directed to furnish the production figures from 2015 to 2017-2018. The move will ensure uninterrupted supply of knee implant by the manufacturers and importer.NPPA can take action against the company in case it receives any complaint of shortage or the company is charging a higher price ," said an official requesting anonymity.

The Mint, New Delhi, 27th September 2017

Comments

Popular posts from this blog

Shrinking footprints of foreign banks in India

Shrinking footprints of foreign banks in India Foreign banks are increasingly shrinking their presence in India and are also becoming more conservative than private and public sector counterparts. While many of them have sold some of their businesses in India as part of their global strategy, some are trying to keep their core expertise intact. Others are branching out to newer areas to continue business momentum.For example, HSBC and Barclays Bank in India have got out of the retail business, whereas corporate-focused Standard Chartered Bank is now trying to increase its focus on retail “Building a retail franchise is a huge exercise and takes a long time. You cannot afford to lose it,” said Shashank Joshi, Bank of Tokyo-Mitsubishi UFJ’s India head.According to the Reserve Bank of India (RBI) data, foreign banks’ combined loan book shrunk nearly 10 per cent from Rs 3.78 trillion in fiscal 2015-16 to Rs 3.42 trillion last financial year. The banking industry, which includes foreign banks…

RBI rushes in to prop up falling rupee

RBI rushes in to prop up falling rupee India’s central bank reportedly intervened in the currency markets on Monday to prevent a further slide in the local unit, which breached the 67 mark to a dollar for the first time in 15 months amid a widening trade gap and runaway import bills fuelled by high crude-oil prices. Some state-owned banks were seen selling dollars aggressively, interventions that market dealers attributed to the central bank’s strategy to stem the decline of the Indian rupee against the US currency. The rupee is the worst performing among a dozen Asian monetary units in the past three months. It lost 4.25 per cent to the dollar during the period, show data from Bloomberg. On Monday, the Reserve Bank of India (RBI) is said to have sold about Rs 800 million collectively on the spot and exchange traded futures markets, dealers said. An email sent to RBI remained unanswered until the publication of this report. The currency market has seen such a strong central bank interven…

GST Refund of Rs 20,000 Cr Pending: Exporters’ Body

GST Refund of Rs  20,000 Cr Pending: Exporters’ Body Refund of over Rs 20,000 crore on account of Goods and Services Tax (GST) is pending with the government with more than half the amount stuck as input tax credit, Federation of Indian Export Organisations said on Tuesday. While claims over Rs7,000 crore were cleared in March, the amount was Rs 1,000 crore in April.However, after exporters’ request, the GST council and tax department are organizing a second phase of Special Refund Fortnight starting May 31, which will enable exporters to draw their refunds at a speedy pace. Many exporters have been unable to file the refund of input tax credit due to technical glitches, exports and claim happened in different months. The major challenge lies on ITC refund especially because the process is partly electronic and partly manual which is cumbersome and add to the transaction cost, the exporters’ body said. On IGST, refunds are getting delayed due to airline and shipping companies not submitt…